A side by side comparison of cytology and biomarkers for bladder cancer detection

Journal of Urology

Volumn 172, Issue 3, 2004, Pages 1123-1126

  Schroeder, Grethchen L ^a   Lorenzo Gomez, Maria Fernanda ^a   Hautmann, Stefan H ^c   Friedrich, Martin G ^c   Ekici, Sinan ^a   Huland, Hartwig ^c   Lokeshwar, Vinata ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Bladder; Bladder neoplasms; Cytology; Hematuria; Tumor markers, biological

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENT FACTOR H; CYTOKERATIN 18; CYTOKERATIN 8; HYALURONIC ACID; HYALURONIDASE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RECURRENCE; CYSTOSCOPY; CYTOLOGY; DIAGNOSTIC ACCURACY; FEMALE; HEMATURIA; HISTOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUMOR DIAGNOSIS; URINALYSIS;

EID: 4143055911     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000134347.14643.ab     Document Type: Article

References (21)

1. Lotan, Y. and Roehrborn, C. G.: Cost-effectiveness of a modified care protocol substituting bladder tumor markers for cystoscopy for the followup of patients with transitional cell carcinoma of the bladder: a decision analytical approach. J Urol, 167: 75, 2002
2. Lotan, Y. and Roehrborn, C. G.: Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses. Urology, 61: 109, 2003
3. Lokeshwar, V. B. and Soloway, M. S.: Current bladder tumor tests: does their projected utility fulfill clinical necessity? J Urol, 165: 1067, 2001
4. Jichlinski, P.: New diagnostic strategies in the detection and staging of bladder cancer. Curr Opin Urol, 13: 351, 2003
5. Friedman, G. D., Carroll, P. R., Cattolica, E. V. and Hiatt, R. A.: Can hematuria be a predictor as well as a symptom or sign of bladder cancer? Cancer Epidemiol Biomarkers Prev, 5: 993, 1996
6. Grossfeld, G. D., Wolf, J. S., Jr., Litwan, M. S., Hricak, H., Shuler, C. L., Agerter, D. C. et al: Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendations. Am Fam Physician, 63: 1145, 2001
7. Kinders, R., Jones, T., Root, R., Bruce, C., Murchison, H., Corey, M. et al: Complement factor H or a related protein is a marker for transitional cell cancer of the bladder. Clin Cancer Res, 4: 2511, 1998
8. Malkowicz, S. B.: The application of human complement factor H-related protein (BTA TRAK) in monitoring patients with bladder cancer. Urol Clin North Am, 27: 63, 2000
9. Boman, H., Hedelin, H. and Holmang, S.: Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence. J Urol, 167: 80, 2002
10. Mungan, N. A., Vriesema, J. L., Thomas, C. M., Kiemeney, L. A. and Witjes, J. A.: Urinary bladder cancer test: a new urinary tumor marker in the follow-up of superficial bladder cancer. Urology, 56: 787, 2000
11. Babjuk, M., Kostirova, M., Mudra, K., Pecher, S., Smolova, H., Pecen, L. et al: Qualitative and quantitative detection of urinary human complement factor H-related protein (BTA stat and BTA TRAK) and fragments of cytokeratins 8, 18 (UBC rapid and UBC IRMA) as markers for transitional cell carcinoma of the bladder. Eur Urol, 41: 34, 2002
12. Mian, C., Lodde, M., Haitel, A., Vigl, E. E., Marberger, M. and Pycha, A.: Comparison of the monoclonal UBC-ELISA test and the NMP22 ELISA test for the detection of urothelial cell carcinoma of the bladder. Urology, 55: 223, 2000
13. Sanchez-Carbayo, M., Ciudad, J., Urrutia, M., Navajo, J. A. and Orfao, A.: Diagnostic performance of the urinary bladder carcinoma antigen ELISA test and multiparametric DNA/cytokeratin flow cytometry in urine voided samples from patients with bladder carcinoma. Cancer, 92: 2811, 2001
14. Lee, J. Y. and Spicer, A. P.: Hyaluronan: a multifunctional, megaDalton, stealth molecule. Curr Opin Cell Biol, 12: 581, 2000
15. Csoka, A. B., Frost, G. I. and Stern, R.: The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol, 20: 499, 2001
16. Lokeshwar, V. B. and Selzer, M. G.: Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells. J Biol Chem, 275: 27641, 2000
17. Hautmann, S. H., Lokeshwar, V. B., Schroeder, G. L., Civantos, F., Duncan, R. C., Gnann, R. et al: Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancer. J Urol, 165: 2068, 2001
18. Lokeshwar, V. B., Obek, C., Pham, H. T., Wei, D., Young, M. J., Duncan, R. C. et al: Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade. J Urol, 163: 348, 2000
19. Lokeshwar, V. B., Schroeder, G. L., Selzer, M. G., Hautmann, S. H., Posey, J. T., Duncan, R. C. et al: Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid-hyaluronidase and BTA-Stat tests. Cancer, 95: 61, 2002
20. Hiatt, R. A. and Ordonez, J. D.: Dipstick urinalysis screening, asymptomatic microhematuria, and subsequent urological cancers in a population-based sample. Cancer Epidemiol Biomarkers Prev, 3: 439, 1994
21. Messing, E. M., Young, T. B., Hunt, V. B., Newton, M. A., Bram, L. L., Vaillancourt, A. et al: Hematuria home screening: repeat testing results. J Urol, 154: 57, 1995